BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12891682)

  • 21. Pelizaeus-Merzbacher disease.
    Koeppen AH; Robitaille Y
    J Neuropathol Exp Neurol; 2002 Sep; 61(9):747-59. PubMed ID: 12230321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes.
    Inoue K
    Adv Exp Med Biol; 2019; 1190():201-216. PubMed ID: 31760646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rabbit paralytic tremor phenotype--a plp1 gene mutation as a model of human Pelizaeus-Merzbacher disease.
    Sypecka J; Domańska-Janik K
    Acta Neurobiol Exp (Wars); 2005; 65(2):221-9. PubMed ID: 15960310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mild phenotype in Pelizaeus-Merzbacher disease caused by a PLP1-specific mutation.
    Osaka H; Koizume S; Aoyama H; Iwamoto H; Kimura S; Nagai J; Kurosawa K; Yamashita S
    Brain Dev; 2010 Oct; 32(9):703-7. PubMed ID: 20022439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Classic Pelizaeus-Merzbacher disease in a girl with an unbalanced chromosomal translocation and functional duplication of PLP1.
    Yiu EM; Farrell SA; Soman T
    Mov Disord; 2009 Oct; 24(14):2171-2. PubMed ID: 19705472
    [No Abstract]   [Full Text] [Related]  

  • 26. A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene.
    Lee ES; Moon HK; Park YH; Garbern J; Hobson GM
    J Neurol Sci; 2004 Sep; 224(1-2):83-7. PubMed ID: 15450775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.
    Lossos A; Elazar N; Lerer I; Schueler-Furman O; Fellig Y; Glick B; Zimmerman BE; Azulay H; Dotan S; Goldberg S; Gomori JM; Ponger P; Newman JP; Marreed H; Steck AJ; Schaeren-Wiemers N; Mor N; Harel M; Geiger T; Eshed-Eisenbach Y; Meiner V; Peles E
    Brain; 2015 Sep; 138(Pt 9):2521-36. PubMed ID: 26179919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the roles of proteolipid protein 1 in the nervous system.
    Garbern JY
    J Neurol Sci; 2005 Feb; 228(2):201-3. PubMed ID: 15694206
    [No Abstract]   [Full Text] [Related]  

  • 29. Myelin mishaps.
    Barkovich AJ
    Ann Neurol; 2007 Aug; 62(2):107-9. PubMed ID: 17683086
    [No Abstract]   [Full Text] [Related]  

  • 30. The PLP mutants from mouse to man.
    Duncan ID
    J Neurol Sci; 2005 Feb; 228(2):204-5. PubMed ID: 15694207
    [No Abstract]   [Full Text] [Related]  

  • 31. Gait abnormalities and progressive myelin degeneration in a new murine model of Pelizaeus-Merzbacher disease with tandem genomic duplication.
    Clark K; Sakowski L; Sperle K; Banser L; Landel CP; Bessert DA; Skoff RP; Hobson GM
    J Neurosci; 2013 Jul; 33(29):11788-99. PubMed ID: 23864668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is involvement of inflammation underestimated in Pelizaeus-Merzbacher disease?
    Marteyn A; Baron-Van Evercooren A
    J Neurosci Res; 2016 Dec; 94(12):1572-1578. PubMed ID: 27661457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A brief history of Pelizaeus-Merzbacher disease and proteolipid protein.
    Koeppen AH
    J Neurol Sci; 2005 Feb; 228(2):198-200. PubMed ID: 15694205
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication.
    Shimojima K; Inoue T; Imai Y; Arai Y; Komoike Y; Sugawara M; Fujita T; Ideguchi H; Yasumoto S; Kanno H; Hirose S; Yamamoto T
    J Hum Genet; 2012 Sep; 57(9):580-6. PubMed ID: 22695888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.
    Sima AA; Pierson CR; Woltjer RL; Hobson GM; Golden JA; Kupsky WJ; Schauer GM; Bird TD; Skoff RP; Garbern JY
    Acta Neuropathol; 2009 Oct; 118(4):531-9. PubMed ID: 19562355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pelizaeus-Merzbacher disease-associated proteolipid protein 1 inhibits oligodendrocyte precursor cell differentiation via extracellular-signal regulated kinase signaling.
    Miyamoto Y; Torii T; Tanoue A; Yamauchi J
    Biochem Biophys Res Commun; 2012 Jul; 424(2):262-8. PubMed ID: 22750001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three new PLP1 splicing mutations demonstrate pathogenic and phenotypic diversity of Pelizaeus-Merzbacher disease.
    Laššuthová P; Žaliová M; Inoue K; Haberlová J; Sixtová K; Sakmaryová I; Paděrová K; Mazanec R; Zámečník J; Šišková D; Garbern J; Seeman P
    J Child Neurol; 2014 Jul; 29(7):924-31. PubMed ID: 23771846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene.
    Hudson LD
    J Child Neurol; 2003 Sep; 18(9):616-24. PubMed ID: 14572140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging of a unique mutation in a family with Pelizaeus-Merzbacher disease.
    Miller E; Widjaja E; Nilsson D; Yoon G; Banwell B; Blaser S
    Am J Med Genet A; 2010 Mar; 152A(3):748-52. PubMed ID: 20186781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic background determines phenotypic severity of the Plp rumpshaker mutation.
    Al-Saktawi K; McLaughlin M; Klugmann M; Schneider A; Barrie JA; McCulloch MC; Montague P; Kirkham D; Nave KA; Griffiths IR
    J Neurosci Res; 2003 Apr; 72(1):12-24. PubMed ID: 12645075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.